163 related articles for article (PubMed ID: 36381630)
1. Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis.
Firouzi J; Sotoodehnejadnematalahi F; Shokouhifar A; Rahimi M; Sodeifi N; Sahranavardfar P; Azimi M; Janzamin E; Safa M; Ebrahimi M
Bioimpacts; 2022; 12(5):415-429. PubMed ID: 36381630
[No Abstract] [Full Text] [Related]
2. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
3. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468.
Abdollahi P; Ebrahimi M; Motamed N; Samani FS
Anticancer Drugs; 2015 Jun; 26(5):487-97. PubMed ID: 25603020
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer.
Rahimi M; Sharifi-Zarchi A; Zarghami N; Geranpayeh L; Ebrahimi M; Alizadeh E
Cell J; 2020 Jan; 21(4):467-478. PubMed ID: 31376329
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
Si L; Fu J; Liu W; Hayashi T; Nie Y; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Mol Cell Biochem; 2020 Jan; 463(1-2):189-201. PubMed ID: 31612353
[TBL] [Abstract][Full Text] [Related]
7. Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells.
Si L; Fu J; Liu W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Arch Biochem Biophys; 2020 May; 685():108284. PubMed ID: 32014401
[TBL] [Abstract][Full Text] [Related]
8. Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway.
Sameri S; Saidijam M; Bahreini F; Najafi R
Nutr Cancer; 2021; 73(8):1389-1399. PubMed ID: 32748663
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carcinoma MCF-7 and MDA-MB-231 cell lines.
Koushki M; Khedri A; Aberomand M; Akbari Baghbani K; Mohammadzadeh G
Iran J Basic Med Sci; 2021 Sep; 24(9):1211-1219. PubMed ID: 35083008
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells.
Kil WH; Kim SM; Lee JE; Park KS; Nam SJ
Ann Surg Treat Res; 2014 Oct; 87(4):167-73. PubMed ID: 25317410
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
12. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
Dastpeyman M; Motamed N; Azadmanesh K; Mostafavi E; Kia V; Jahanian-Najafabadi A; Shokrgozar MA
Med Oncol; 2012 Dec; 29(4):2512-8. PubMed ID: 22101790
[TBL] [Abstract][Full Text] [Related]
14. Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).
Maleki N; Yavari N; Ebrahimi M; Faisal Faiz A; Khosh Ravesh R; Sharbati A; Panji M; Lorian K; Gravand A; Abbasi M; Abazari O; Shafiee Mehr M; Eskandari Y
Gene; 2022 May; 823():146275. PubMed ID: 35189245
[TBL] [Abstract][Full Text] [Related]
15. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
[TBL] [Abstract][Full Text] [Related]
16. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
17. Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype.
Laranjo M; Carvalho MJ; Costa T; Alves A; Oliveira RC; Casalta-Lopes J; Cordeiro P; Botas F; Abrantes AM; Paiva A; Oliveira C; Botelho MF
Breast; 2018 Apr; 38():22-29. PubMed ID: 29182983
[TBL] [Abstract][Full Text] [Related]
18. Effect of Silibinin on Maspin and ERα Gene Expression in MCF-7 Human Breast Cancer Cell Line.
Karimi M; Babaahmadi-Rezaei H; Mohammadzadeh G; Ghaffari MA
Iran J Pathol; 2017; 12(2):135-143. PubMed ID: 29515635
[TBL] [Abstract][Full Text] [Related]
19. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells.
Bayram D; Çetin ES; Kara M; Özgöçmen M; Candan IA
Hum Exp Toxicol; 2017 Jun; 36(6):573-586. PubMed ID: 27402681
[TBL] [Abstract][Full Text] [Related]
20. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
